Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine and Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury
NCT07348016Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Aug 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of liposomal bupivacaine in rotator cuff injury and adhesive capsulitis (AC) (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoints: University of California-Los Angeles Shoulder Score at 12 months, Constant-Murley Shoulder Score at 12 months and 1 more. Started Aug 2025; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
rotator cuff injuryadhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT07348016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07348016.